Compound information
- Natural Products
- ZC2838277
- Molecular Formula
- C20H18N2OS
- Molecular Weight
- 334.113984196 g/mol
- Structure
-
- IUPAC Name
- (1S,2S)-N-(5-methyl-4-phenyl-thiazol-2-yl)-2-phenyl-cyclopropanecarboxamide
- InChI
- InChI=1S/C20H18N2OS/c1-13-18(15-10-6-3-7-11-15)21-20(24-13)22-19(23)17-12-16(17)14-8-4-2-5-9-14/h2-11,16-17H,12H2,1H3,(H,21,22,23)/t16-,17+/m1/s1
- InChI Key
- OIHCVXXZJIHZQS-SJORKVTESA-N
- SMILES
- Cc1sc(NC(=O)[C@H]2C[C@@H]2c2ccccc2)nc1-c1ccccc1
- Source
- ZINC000000028424
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 24 | Ring Count | 4 |
| Heteroatom Count | 4 | Rotatable Bond Count | 4 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 41.99 Å2 | LogP | 4.844 |
| LogS | -5.288 | LogD | 5.127 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.098 | Pgp substrate | 0.012 |
| HIA | 0.96 | F20 % | 0.992 |
| F30 % | 0.882 | Caco-2 | -4.596 |
| MDCK | -4.61 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.019 | PPB | 99.74 |
| VD | 1.095 | Fu | 1.987 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.962 | CYP1A2 substrate | 0.844 |
| CYP2A6 substrate | 0.843 | CYP2B6 substrate | 0.85 |
| CYP2C19 inhibitor | 0.869 | CYP2C19 substrate | 0.995 |
| CYP2C8 substrate | 0.895 | CYP2C9 inhibitor | 0.562 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.153 |
| CYP2D6 substrate | 0.792 | CYP2E1 substrate | 0.502 |
| CYP3A4 inhibitor | 0.215 | CYP3A4 substrate | 1.0 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.131 | CL | 10.0 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.012 | Hepatotoxicity | 0.922 |
| Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.153 |
| FDAMDD | 0.716 | Skin Sensitization | 0.007 |
| Carcinogenicity | 0.08 | Eye Corrosion | 0.007 |
| Eye Irritation | 0.347 | Respiratory Toxicity | 0.673 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 1.765 | IGC50 | 4.204 |
| LC50FM | 5.77 | LC50DM | 5.774 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.881 | NR-AR-LBD | 0.512 |
| NR-AhR | 0.978 | NR-Aromatase | 0.338 |
| NR-ER | 0.916 | NR-ER-LBD | 0.841 |
| NR-PPAR-gamma | 0.872 | SR-ARE | 0.639 |
| SR-ATAD5 | 0.839 | SR-HSE | 0.478 |
| SR-MMP | 0.951 | SR-p53 | 0.753 |
Similar covalent drugs
No similar covalent drugs found for this compound.